Benzinga Podcasts are a collection of various shows Benzinga staff & friends record about the stock market, crypto, life, inspiration and business related stories. Benzinga Cannabis Insider is a ...

Take a look at some of Benzinga’s favorites. You have found stocks to buy now cheap, but you need a partner that makes the process simple. When you choose the best broker for your situation ...

Discover opportunities the rest of the world is missing out on. Benzinga’s team has curated small cap stocks with compelling stories and stories that most investors have never heard of.

The Benzinga Stock Whisper Index highlights five stocks each week seeing an increase in interest from readers. Several stocks rejoin the index with news and huge increases in interest from readers.

Looking for a comprehensive and reliable source of stock market news? Benzinga creates actionable, market-moving stock news content that is all written in-house. Benzinga’s editorial team cuts ...

Benzinga readers can review the latest analyst takes on their favorite stocks by visiting Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings ...

According to data from Benzinga Pro, the stock is down more than 27% over the past month. Read Next: Kerrisdale Capital Is Short Lumen Technologies: Here’s What To Know The company announced the ...

allowing you to participate more actively in the construction of your portfolio. Consider Benzinga's favorite brokerages and penny stock apps.

According to data from Benzinga Pro, SolarEdge shares are trading near the stock’s 50-day moving average of $27.52 and 39.44% of shares are being sold short. When trying to assess whether or not ...

Benzinga’s picks for the best crypto brokers for the month of August 2024 include Coinbase and eToro. In the world of cryptocurrency trading and investing, a reliable crypto broker is essential.

Benzinga Money is a reader-supported publication. We may earn a commission from the advertisers associated with this article. Read our Advertiser Discloser. The world’s biggest asset managers ...

UnitedHealth will remove AbbVie's Humira from its preferred drug lists by 2025, opting for lower-cost biosimilars like Amgen's Amjevita, in a move aimed at cutting prescription costs. Shares of ...